Colorectal Cancer: Histopathologic Differences in Tumor Characteristics Between Patients With and Without Diabetes

Howlander N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute, Bethesda, MD. Available at: http://seer.cancer.gov/statfacts/html/colorect.html. Colorectal Cancer Facts & Figures 2011-2013. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-028323.pdf. Haggar, 2009, Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors, Clin Colon Rectal Surg, 22, 191, 10.1055/s-0029-1242458 Giovannucci, 2002, Modifiable risk factors for colon cancer, Gastroenterol Clin North Am, 31, 925, 10.1016/S0889-8553(02)00057-2 Larsson, 2005, Diabetes mellitus and risk of colorectal cancer: a meta-analysis, J Natl Cancer Inst, 97, 1679, 10.1093/jnci/dji375 Huxley, 2009, The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence, Int J Cancer, 125, 171, 10.1002/ijc.24343 Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Available at: http://www.cdc.gov/diabetes/pubs/factsheet11.htm. Giovannucci, 2010, Diabetes and cancer: a consensus report, Diabetes Care, 33, 1674, 10.2337/dc10-0666 Meyerhardt, 2003, Impact of diabetes mellitus on outcomes in patients with colon cancer, J Clin Oncol, 21, 433, 10.1200/JCO.2003.07.125 Vigneri, 2009, Diabetes and cancer, Endocr Relat Cancer, 16, 1103, 10.1677/ERC-09-0087 Van de Poll-Franse, 2012, Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis, Diabetologia, 55, 2163, 10.1007/s00125-012-2555-8 Denley, 2007, Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors, Mol Cell Biol, 27, 3569, 10.1128/MCB.01447-06 Gallagher, 2011, Minireview: IGF, insulin, and cancer, Endocrinology, 152, 2546, 10.1210/en.2011-0231 Ulanet, 2010, Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy, Proc Natl Acad Sci U S A, 107, 10791, 10.1073/pnas.0914076107 Masur, 2011, Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation, Br J Cancer, 104, 345, 10.1038/sj.bjc.6606050 Bowker, 2006, Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin, Diabetes Care, 29, 254, 10.2337/diacare.29.02.06.dc05-1558 Giovannucci, 2001, Insulin, insulin-like growth factors and colon cancer: a review of the evidence, J Nutr, 131, 3109S Mardilovich, 2009, Expression and function of the insulin receptor substrate proteins in cancer, Cell Commun Signal CCS, 7, 14, 10.1186/1478-811X-7-14 LeRoith, 2003, The insulin-like growth factor system and cancer, Cancer Lett, 195, 127, 10.1016/S0304-3835(03)00159-9 Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809 2009 Han, 2011, Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases, Breast J, 17, 223, 10.1111/j.1524-4741.2011.01069.x 1989, 32 Lim, 2010, Prognostic significance of lymphovascular invasion in sporadic colorectal cancer, Dis Colon Rectum, 53, 377, 10.1007/DCR.0b013e3181cf8ae5 O’Connell, 2004, Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging, J Natl Cancer Inst, 96, 1420, 10.1093/jnci/djh275 Compton, 2000, Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999, Arch Pathol Lab Med, 124, 979, 10.5858/2000-124-0979-PFICC Bresalier, 1991, Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis, J Clin Invest, 87, 1037, 10.1172/JCI115063 Sung, 2008, Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma, Mod Pathol, 21, 1533, 10.1038/modpathol.2008.170 Hamada, 1992, Endocrine cells and prognosis in patients with colorectal carcinoma, Cancer, 69, 2641, 10.1002/1097-0142(19920601)69:11<2641::AID-CNCR2820691104>3.0.CO;2-L Hyngstrom, 2012, Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base, Ann Surg Oncol, 19, 2814, 10.1245/s10434-012-2321-7 Tung, 1996, Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study, Am J Gastroenterol, 91, 2195 Kang, 2005, A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum, Dis Colon Rectum, 48, 1161, 10.1007/s10350-004-0932-1 Arends, 1986, The occurrence and clinicopathological significance of serotonin immunoreactive cells in large bowel carcinoma, J Pathol, 149, 97, 10.1002/path.1711490204 Ogino, 2006, Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component, Mod Pathol, 19, 59, 10.1038/modpathol.3800482 Börger, 2007, Signet ring cell differentiation in mucinous colorectal carcinoma, J Pathol, 212, 278, 10.1002/path.2181 Astler, 1954, The prognostic significance of direct extension of carcinoma of the colon and rectum, Ann Surg, 139, 846, 10.1097/00000658-195406000-00015 Shonka, 2006, Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer, Med Oncol, 23, 515, 10.1385/MO:23:4:515 Nagel, 2012, Less advanced stages of colon cancer in patients with type 2 diabetes mellitus: an unexpected finding?, Exp Clin Endocrinol Diabetes, 120, 224, 10.1055/s-0031-1299704 Gatta, 2003, Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology, Eur J Cancer, 39, 2214, 10.1016/S0959-8049(03)00549-5 Caldarella, 2013, Trends in colorectal incidence by anatomic subsite from 1985 to 2005: a population-based study [e-pub], Int J Colorectal Dis, 10.1007/s00384-013-1672-2 Iacopetta, 2002, Are there two sides to colorectal cancer?, Int J Cancer, 101, 403, 10.1002/ijc.10635 Huang, 2011, Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease, J Cancer Res Clin Oncol, 137, 211, 10.1007/s00432-010-0879-7 Nomura, 1991, Prospective study of serum cholesterol levels and large-bowel cancer, J Natl Cancer Inst, 83, 1403, 10.1093/jnci/83.19.1403 [No authors listed.], 1981, From the NIH: cholesterol and noncardiovascular mortality, JAMA J Am Med Assoc, 246, 731, 10.1001/jama.1981.03320070015005 Williams, 1981, Cancer incidence by levels of cholesterol, JAMA, 245, 247, 10.1001/jama.1981.03310280023021 Poynter, 2005, Statins and the risk of colorectal cancer, N Engl J Med, 352, 2184, 10.1056/NEJMoa043792 Hiatt, 1986, Serum cholesterol and the incidence of cancer in a large cohort, J Chronic Dis, 39, 861, 10.1016/0021-9681(86)90034-2 Cambien, 1980, Total serum cholesterol and cancer mortality in a middle-aged male population, Am J Epidemiol, 112, 388, 10.1093/oxfordjournals.aje.a113004 Yang, 2013, Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients, Cancer, 119, 1512, 10.1002/cncr.27923 Giouleme, 2011, Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms, World J Gastroenterol, 17, 444, 10.3748/wjg.v17.i4.444 Singh, 2013, Anti-diabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis [e-pub], Cancer Epidemiol Biomarkers Prev, 10.1158/1055-9965.EPI-13-0429 Gallagher, 2013, Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?, Curr Opin Endocrinol Diabetes Obes, 20, 485, 10.1097/01.med.0000433065.16918.83 Pasche, 2013, Differential effects of aspirin before and after diagnosis of colorectal cancer, JAMA, 309, 2598, 10.1001/jama.2013.6600 Pollak, 2008, Insulin and insulin-like growth factor signalling in neoplasia, Nat Rev Cancer, 8, 915, 10.1038/nrc2536